Validating the ALBI grade: Its current and future use in HCC prognostication.

Chan, Anthony W H; Leung, Howard H W; Chong, Charing C N; Chan, Stephen L

Chan, Anthony W H; Leung, Howard H W; Chong, Charing C N; Chan, Stephen L.

Afiliação

Chan AWH; Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong. Electronic address: awh_chan@cuhk.edu.hk.
Leung HHW; Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
Chong CCN; Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Chan SL; Department of Clinical Oncology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong; Institute of Digestive Disease, Partner State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

J Hepatol ; 66(3): 661-663, 2017 03.

Article em En | MEDLINE | ID: mdl-27890792

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google